These findings support our metabolomic and transcriptomic analyses, demonstrating that suppression of NAF-1 results in a metabolic shift of cancer cells to be even more dependent on glycolysis, making NAF-1(−) cells more susceptible to the glycolysis inhibitor 2-DG compared to control cells. Here, NAF1 is linked to cancer.